-  This bill is not active in this session.
 

A05762 Summary:

BILL NOA05762
 
SAME ASSAME AS S04497
 
SPONSORPaulin
 
COSPNSRSayegh, Englebright, Griffin, Fahy, Simon, Barclay, Crouch, DeStefano, Jacobson, Schmitt, Ortiz, Arroyo, Cook, Steck, Raia, Thiele, McDonald, Benedetto, Otis
 
MLTSPNSRJean-Pierre
 
Add Art 27-L §2799-u, Pub Health L
 
Establishes the rare disease advisory council; advise and consult on policy matters relating to rare disease; twenty-one appointed members.
Go to top    

A05762 Actions:

BILL NOA05762
 
02/19/2019referred to health
04/02/2019reported referred to ways and means
05/14/2019reported
05/16/2019advanced to third reading cal.350
05/22/2019passed assembly
05/22/2019delivered to senate
05/22/2019REFERRED TO FINANCE
06/04/2019SUBSTITUTED FOR S4497
06/04/20193RD READING CAL.864
06/04/2019PASSED SENATE
06/04/2019RETURNED TO ASSEMBLY
12/17/2019delivered to governor
12/20/2019signed chap.719
12/20/2019approval memo.66
Go to top

A05762 Committee Votes:

HEALTH Chair:Gottfried DATE:04/02/2019AYE/NAY:24/0 Action: Favorable refer to committee Ways and Means
GottfriedAyeRaiaAye
SchimmingerAyeMcDonoughAye
GalefAyeRaAye
DinowitzAyeGarbarinoAye
CahillAyeByrneAye
PaulinAyeByrnesAye
CymbrowitzAyeAshbyAye
GuntherExcused
RosenthalAye
HevesiExcused
JaffeeAye
SteckAye
AbinantiAye
BraunsteinAye
KimAye
SolagesAye
BichotteAye
BarronAye
SayeghAye

WAYS AND MEANS Chair:Weinstein DATE:05/14/2019AYE/NAY:32/0 Action: Favorable
WeinsteinAyeBarclayAye
LentolAyeCrouchAye
SchimmingerAyeFitzpatrickAye
GanttExcusedHawleyAye
GlickAyeMalliotakisAye
NolanAyeMontesanoAye
PretlowAyeRaAye
PerryExcusedBlankenbushAye
ColtonAyePalmesanoAye
CookAyeNorrisAye
CahillAye
AubryAye
ThieleAye
CusickExcused
OrtizAye
BenedettoAye
WeprinAye
RodriguezAye
RamosAye
BraunsteinAye
McDonaldAye
RozicAye
SimotasAye
DinowitzAye
MillerAye

Go to top

A05762 Floor Votes:

DATE:05/22/2019Assembly Vote  YEA/NAY: 146/0
Yes
Abbate
Yes
Crespo
ER
Gantt
Yes
LiPetri
Yes
Perry
Yes
Simon
Yes
Abinanti
Yes
Crouch
Yes
Garbarino
Yes
Lupardo
Yes
Pheffer Amato
Yes
Simotas
Yes
Arroyo
Yes
Cruz
Yes
Giglio
Yes
Magnarelli
Yes
Pichardo
Yes
Smith
Yes
Ashby
Yes
Cusick
Yes
Glick
Yes
Malliotakis
Yes
Pretlow
Yes
Smullen
Yes
Aubry
Yes
Cymbrowitz
Yes
Goodell
Yes
Manktelow
Yes
Quart
Yes
Solages
Yes
Barclay
ER
Davila
Yes
Gottfried
Yes
McDonald
Yes
Ra
Yes
Stec
Yes
Barnwell
Yes
De La Rosa
Yes
Griffin
Yes
McDonough
Yes
Raia
Yes
Steck
Yes
Barrett
Yes
DenDekker
Yes
Gunther
Yes
McMahon
Yes
Ramos
Yes
Stern
Yes
Barron
Yes
DeStefano
Yes
Hawley
Yes
Mikulin
Yes
Raynor
Yes
Stirpe
Yes
Benedetto
Yes
Dickens
Yes
Hevesi
Yes
Miller B
Yes
Reilly
Yes
Tague
Yes
Bichotte
Yes
Dilan
Yes
Hunter
Yes
Miller MG
Yes
Reyes
Yes
Taylor
Yes
Blake
Yes
Dinowitz
Yes
Hyndman
Yes
Miller ML
Yes
Richardson
Yes
Thiele
Yes
Blankenbush
Yes
DiPietro
Yes
Jacobson
Yes
Montesano
Yes
Rivera
Yes
Titus
Yes
Brabenec
Yes
D'Urso
Yes
Jaffee
Yes
Morinello
Yes
Rodriguez
Yes
Vanel
Yes
Braunstein
Yes
Eichenstein
Yes
Jean-Pierre
Yes
Mosley
Yes
Romeo
Yes
Walczyk
Yes
Bronson
Yes
Englebright
Yes
Johns
Yes
Niou
Yes
Rosenthal D
Yes
Walker
Yes
Buchwald
Yes
Epstein
Yes
Jones
Yes
Nolan
Yes
Rosenthal L
Yes
Wallace
Yes
Burke
Yes
Fahy
Yes
Joyner
Yes
Norris
Yes
Rozic
Yes
Walsh
Yes
Buttenschon
Yes
Fall
Yes
Kim
Yes
O'Donnell
Yes
Ryan
Yes
Weinstein
Yes
Byrne
Yes
Fernandez
Yes
Kolb
Yes
Ortiz
Yes
Salka
Yes
Weprin
Yes
Byrnes
Yes
Finch
Yes
Lalor
Yes
Otis
Yes
Santabarbara
Yes
Williams
Yes
Cahill
Yes
Fitzpatrick
Yes
Lavine
ER
Palmesano
Yes
Sayegh
Yes
Woerner
Yes
Carroll
Yes
Friend
Yes
Lawrence
Yes
Palumbo
Yes
Schimminger
Yes
Wright
Yes
Colton
Yes
Frontus
Yes
Lentol
ER
Paulin
Yes
Schmitt
Yes
Zebrowski
Yes
Cook
Yes
Galef
Yes
Lifton
Yes
Peoples-Stokes
Yes
Seawright
Yes
Mr. Speaker

‡ Indicates voting via videoconference
Go to top

A05762 Text:



 
                STATE OF NEW YORK
        ________________________________________________________________________
 
                                          5762
 
                               2019-2020 Regular Sessions
 
                   IN ASSEMBLY
 
                                    February 19, 2019
                                       ___________
 
        Introduced  by  M.  of  A.  PAULIN,  SAYEGH, ENGLEBRIGHT, GRIFFIN, FAHY,
          SIMON, BARCLAY, CROUCH, DeSTEFANO, JACOBSON, SCHMITT -- read once  and
          referred to the Committee on Health
 
        AN  ACT  to amend the public health law, in relation to establishing the
          rare disease advisory council

          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
 
     1    Section  1.  The  public health law is amended by adding a new article
     2  27-L to read as follows:
     3                                ARTICLE 27-L
     4                        RARE DISEASE ADVISORY COUNCIL
     5  Section 2799-u. Rare disease advisory council.
     6    § 2799-u. Rare disease advisory council. 1. There shall be established
     7  within the department a rare disease  advisory  council  to  advise  and
     8  consult  on policy matters relating to rare disease. For the purposes of
     9  this section, rare disease shall mean  any  disease  or  condition  that
    10  affects less than 200,000 people in the United States.
    11    2.  The council shall be composed of twenty-one members consisting of:
    12  seventeen members shall be appointed by the governor, two members  shall
    13  be  appointed  by  the speaker of the assembly, and two members shall be
    14  appointed by the temporary president of the senate. The  governor  shall
    15  designate  the  commissioner,  or  his  or her designee, as chair of the
    16  council, and the superintendent of the department of financial services,
    17  or his or her designee, as co-chair of the council. The council shall at
    18  all times include in  its  membership  the  following,  which  shall  be
    19  appointed by the governor: two physicians licensed and practicing in the
    20  state   with   experience  researching,  diagnosing,  or  treating  rare
    21  diseases; one registered nurse or  advanced  practice  registered  nurse
    22  licensed  and  practicing  in  the  state  with experience treating rare
    23  diseases; two hospital administrators from hospitals in the  state  that
    24  provide  care to persons diagnosed with a rare disease, one of whom must
 
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD07491-01-9

        A. 5762                             2
 
     1  represent a hospital in which the  scope  of  service  focuses  on  rare
     2  diseases  of pediatric patients; three persons age eighteen or older who
     3  either have a rare disease or are a caregiver of a person  with  a  rare
     4  disease; two representatives of a rare disease patient organization that
     5  operates in the state; one pharmacist with experience with drugs used to
     6  treat  rare  diseases; one representative of the biotechnology industry;
     7  one representative of health insurance  companies;  one  member  of  the
     8  scientific  community  who  is engaged in rare disease research; and one
     9  genetic counselor with experience providing services  to  persons  diag-
    10  nosed with a rare disease or caregivers of those persons.
    11    3.  Members of the advisory council shall serve at the pleasure of the
    12  appointing authority. Vacancies on the advisory council shall be  filled
    13  in  the same manner as the original appointment. Members of the advisory
    14  council shall receive no compensation for their  services,  but  may  be
    15  reimbursed for necessary and actual expenses incurred in the performance
    16  of their duties hereunder.
    17    4. The advisory council shall meet at least three times in each calen-
    18  dar year. The council shall meet at the request of its chairs.
    19    5. The advisory council's duties may include, but are not limited to:
    20    a.  Convening  public  hearings, and receiving and considering reports
    21  and testimony from individuals, the department, health  care  providers,
    22  and  public  or  private organizations recognized as having expertise in
    23  rare diseases, as well as other interested parties, to assist the  coun-
    24  cil in developing recommendations under this section;
    25    b. Studying the economic burden of the treatment of rare diseases with
    26  regard to quality of care, health care coverage, and access to treatment
    27  and services;
    28    c.  Developing  recommendations pertaining to the impact of particular
    29  health care coverage and  the  impact  of  particular  coverage  on  the
    30  provision of treatment and care services;
    31    d.  Identifying  best  practices  for rare diseases that could improve
    32  treatment of rare diseases in New York state; and
    33    e. Developing a list of existing,  publicly  accessible  resources  on
    34  research, diagnosis, treatment, coverage options, and education relating
    35  to  rare  diseases, which shall be published on the department's website
    36  upon completion.
    37    6. The council shall prepare and submit a written report no later than
    38  October first, two thousand twenty, and biennially  thereafter,  to  the
    39  governor, speaker of the assembly, and temporary president of the senate
    40  that  sets  forth  the  findings  and  recommendations of the council on
    41  matters within the scope of its duties as set forth in this section.
    42    § 2. This act shall take effect immediately.
Go to top